Health July 05, 2021 New COVID variants: what you should know New variants of the virus that causes COVID-19 make it spread easier and faster. A TecSalud expert answers questions about these variants.
Health July 01, 2021 Study shows CureVac vaccine is 100% effective against death from COVID Phase 3 study results have shown that the German CureVac vaccine is 100% effective at preventing hospitalization or death from any variant of the COVID-19 virus.
Health June 25, 2021 The doctor who created an innovative health system in Mexico Dr. Guillermo Torre, researcher, clinician, and surgeon, has helped establish an innovative system at TecSalud, Tec de Monterrey’s health system.
Research June 10, 2021 CureVac vaccine protocol: public-private collaboration success story Clinical trials for the CureVac vaccine carried out by private institutions such as TecSalud and the Mexican government have made public-private synergy necessary.
Health May 27, 2021 “Doc McStuffins” touches the hearts of children with her magic Dr. Cecilia Britton, aka “Doc McStuffins,” is a pediatric cardiologist at TecSalud who collaborates with social programs to help children.
Health May 03, 2021 Mexican CureVac vaccine studies move ahead with TecSalud TecSalud demonstrates research leadership by participating in the German CureVac COVID-19 vaccine clinical trial.
Institution March 01, 2021 Bill Gates: Tec produces world-class engineers Using Tec de Monterrey as an example, Bill Gates, philanthropist and founder of Microsoft, suggested that Mexico should focus on education as the key to its future development.
Research February 24, 2021 Nobel laureate calls for trust in scientific consensus on vaccines Aaron Ciechanover, an Israeli scientist who won the 2004 Nobel Prize in Chemistry, calls for increased media campaigns in favor of COVID-19 vaccination.
Research February 24, 2021 Genome sequencing: work of new laboratory from Tec and FEMSA The Tec BASE Genome Sequencing Laboratory has specialized equipment from American company Ilumina, one of the most prominent in the field.
Health February 17, 2021 TecSalud begins Phase 3 trials of German CureVac vaccine in Mexico TecSalud has started administering the vaccine candidate from German pharmaceutical company CureVac for its Phase 3 clinical trials.
